"Nervous System Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
Descriptor ID |
D009422
|
MeSH Number(s) |
C10
|
Concept/Terms |
Nervous System Diseases- Nervous System Diseases
- Disease, Nervous System
- Diseases, Nervous System
- Nervous System Disease
- Neurologic Disorders
- Disorder, Neurologic
- Disorders, Neurologic
- Neurologic Disorder
- Neurological Disorders
- Disorder, Neurological
- Disorders, Neurological
- Neurological Disorder
- Nervous System Disorders
- Disorder, Nervous System
- Disorders, Nervous System
- Nervous System Disorder
|
Below are MeSH descriptors whose meaning is more general than "Nervous System Diseases".
Below are MeSH descriptors whose meaning is more specific than "Nervous System Diseases".
This graph shows the total number of publications written about "Nervous System Diseases" by people in this website by year, and whether "Nervous System Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2013 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 1 | 2 |
2020 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nervous System Diseases" by people in Profiles.
-
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome. Brain. 2022 10 21; 145(10):3383-3390.
-
SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020 10 15; 39(20):e106230.
-
Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder. Brain. 2020 08 01; 143(8):2437-2453.
-
Challenges of palliative care in children with inborn metabolic diseases. Orphanet J Rare Dis. 2018 07 09; 13(1):112.
-
Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018 04; 556(7701):332-338.
-
Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease. Am J Hum Genet. 2016 Jul 07; 99(1):188-94.
-
mRNA metabolism and neuronal disease. FEBS Lett. 2015 Jun 22; 589(14):1598-606.
-
Mutations in GMPPA cause a glycosylation disorder characterized by intellectual disability and autonomic dysfunction. Am J Hum Genet. 2013 Oct 03; 93(4):727-34.
-
A novel OPA3 mutation revealed by exome sequencing: an example of reverse phenotyping. JAMA Neurol. 2013 Jun; 70(6):783-7.
-
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet. 2010 Nov; 42(11):1021-6.